Loading…
Alumis Inc. is projected to rise to $34.42 by 2027, a +22% move from its current price of $28.31. ALMS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $27.31 | $28.32 | $29.37 | +0.04% |
| Jul 13 | $26.91 | $28.33 | $29.83 | +0.08% |
| Jul 14 | $26.61 | $28.35 | $30.19 | +0.13% |
| Jul 15 | $26.36 | $28.36 | $30.50 | +0.17% |
| Jul 16 | $26.15 | $28.37 | $30.78 | +0.21% |
| Jul 17 | $25.96 | $28.38 | $31.03 | +0.25% |
| Jul 18 | $25.78 | $28.39 | $31.27 | +0.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $25.78 | $28.39 | $31.27 | +0.30% |
| Week 2 | $24.85 | $28.48 | $32.64 | +0.60% |
| Week 3 | $24.17 | $28.56 | $33.76 | +0.89% |
| Week 4 | $23.62 | $28.65 | $34.75 | +1.19% |
| Week 5 | $23.16 | $28.73 | $35.65 | +1.50% |
| Week 6 | $22.75 | $28.82 | $36.50 | +1.80% |
| Week 7 | $22.39 | $28.90 | $37.31 | +2.10% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Alumis Inc. is a clinical stage biopharmaceutical company that focuses on the development and commercialization of medicines for autoimmune disorders. It offers envudeucitinib, a TYK2 inhibitor for plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor that is in Phase 1 for neuroinflammatory and neurodegenerative diseases.
The company also develops lonigutamab, a monoclonal antibody targeting IGF-1R for the treatment of thyroid eye diseases, and interferon regulatory factor 5 (IRF5) to address immune dysfunction. Alumis was formerly Esker Therapeutics, Inc. and changed its name to Alumis Inc.
in January 2022. Alumis was incorporated in 2021 and is headquartered in South San Francisco, California.
Alumis Inc. (ALMS) is currently priced at $29.27 with a market cap of $3.73B and a market-rank of 1604. The stock’s near-term technical picture is bullish, with a 30-day range from $23.00 to $37.25 and current resistance at $29.27.
A major floor 48.6% below — a decisive break under it would weaken the trend.
The nearest floor, 32.9% below — buyers have tended to step in here.
The nearest ceiling, 7.0% above — a clean break opens room to run.
A major ceiling 31.3% above — clearing it would confirm fresh momentum.
Key ALMS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ALMS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $28.98 | Sell | $28.76 | Sell |
| MA 10 | $27.97 | Buy | $27.84 | Buy |
| MA 20 | $25.78 | Buy | $26.27 | Buy |
| MA 50 | $23.73 | Buy | $24.58 | Buy |
| MA 100 | $24.62 | Buy | $23.08 | Buy |
| MA 200 | $18.18 | Buy | $19.47 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.82 | Neutral |
| Stoch RSI (14) | 7.48 | Buy |
| CCI (20) | 76.97 | Neutral |
| Williams %R (14) | -34.37 | Info |
| MACD (12,26,9) | 0.39 | Buy |
| ROC (12) | 15.50 | Buy |
| Bollinger %B (20,2) | 0.75 | Neutral |
| Stochastic %K (14) | 65.63 | Neutral |
| TRIX (15) | 0.88 | Buy |
| Awesome (5,34) | 5.29 | Buy |
| Ultimate (7,14,28) | 58.35 | Neutral |
| Momentum (10) | 3.28 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 30.17 | Sell |
| ADX (14) | 28.12 | Buy |
| ATR (14) | 0.88 | Info |
The 30-day technical picture is bullish with RSI14 at 70. The stock trades above the 50-day and 200-day moving averages, with SMA50 at $23.44 and SMA200 at $17.80. Support is at $18.99 and resistance at $29.27, framing a 30-day range of $23.00 to $37.25.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.31 | $28.31 | $38.97 | 0% | Neutral | |
| $26.55 | $34.42 | $47.70 | +22% | Bullish | |
| $30.17 | $40.66 | $59.06 | +44% | Bullish | |
| $36.62 | $50.97 | $76.78 | +80% | Bullish | |
| $37.54 | $53.78 | $83.53 | +90% | Bullish | |
| $36.66 | $53.93 | $86.00 | +90% | Bullish | |
| $36.92 | $55.67 | $90.91 | +97% | Bullish | |
| $37.98 | $58.64 | $97.82 | +107% | Bullish | |
| $46.66 | $73.67 | $125.32 | +160% | Bullish | |
| $53.48 | $86.30 | $149.47 | +205% | Bullish | |
| $58.76 | $104.82 | $195.71 | +270% | Bullish | |
| $112.08 | $239.61 | $498.25 | +746% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $8.31 | $28.31 | $33.33 | +0.00% |
| August 2026 | $23.31 | $27.77 | $34.16 | -1.90% |
| September 2026 | $24.47 | $29.43 | $36.72 | +5.95% |
| October 2026 | $24.74 | $29.99 | $37.88 | +1.91% |
| November 2026 | $24.13 | $29.46 | $37.60 | -1.77% |
| December 2026 | $24.62 | $30.25 | $38.97 | +2.69% |
Click any year to see its month-by-month ALMS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Alumis Inc.'s 2026 outlook centres on $28.31, within a $8.31 to $38.97 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, ALMS could reach as high as $47.70, with a base case around $34.42 and support toward $26.55 — roughly +22% from $28.31. Buyers look set to stay in control over this stretch.
Expect ALMS to range from $30.17 to $59.06 through 2028. The $40.66 average target implies a +44% move from current prices. That is up +18% on the projected 2027 average. Momentum favours further upside here.
The ALMS price prediction for 2029 points to an average of $50.97 (low $36.62, high $76.78) — a potential gain of +80% on today's $28.31. Buyers look set to stay in control over this stretch.
In 2030, ALMS is projected to trade between $37.54 and $83.53, averaging $53.78 — a potential gain of +90% from today's $28.31. That is up +6% on the projected 2029 average. Momentum favours further upside here.
Alumis Inc.'s 2031 outlook centres on $53.93, within a $36.66 to $86.00 range. That is up 0% on the projected 2030 average. That marks a +90% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, ALMS could reach as high as $90.91, with a base case around $55.67 and support toward $36.92 — roughly +97% from $28.31. Momentum favours further upside here.
Expect ALMS to range from $37.98 to $97.82 through 2033. The $58.64 average target implies a +107% move from current prices. That is up +5% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The ALMS price prediction for 2034 points to an average of $73.67 (low $46.66, high $125.32) — a potential gain of +160% on today's $28.31. Momentum favours further upside here.
In 2035, ALMS is projected to trade between $53.48 and $149.47, averaging $86.30 — a potential gain of +205% from today's $28.31. That is up +17% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Alumis Inc.'s 2040 outlook centres on $104.82, within a $58.76 to $195.71 range. That is up +21% on the projected 2035 average. That marks a +270% change versus current levels. Momentum favours further upside here.
By 2050, ALMS could reach as high as $498.25, with a base case around $239.61 and support toward $112.08 — roughly +746% from $28.31. Buyers look set to stay in control over this stretch.
Investing $1,000 in ALMS today (≈ 35.323207 ALMS) could be worth
$8,463.81
+$7,463.81 (+746%) by 2050 · US Dollar
Based on the average projected ALMS price of $239.61 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ALMSwould be worth at today's price.
$1,000 invested in ALMS on Jul 10, 2025 (≈ 280.898881 ALMS) would be worth
$7,952.25
+$6,952.25 (+695.2%) today · 7.95× · US Dollar
Based on a ALMS entry price of $3.56 vs. today's $28.31.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $26.5 | $1,068.3 | +6.8% |
| 1 month ago | $20.06 | $1,411.27 | +41.1% |
| 3 months ago | $23.05 | $1,228.2 | +22.8% |
| 6 months ago | $21.09 | $1,342.34 | +34.2% |
| 1 year ago | $3.56 | $7,952.25 | +695.2% |
| All time (2.0y) ago | $13.3 | $2,128.57 | +112.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ALMS forecast.
Our base-case forecast reaches $57.00 around 2033.
Implied market cap at $57.00: $7.04B
The multi-year forecast shows a neutral stance in 2026 with min $8.31, avg $29.27, max $40.75 and ROI 0. From 2027 onward the outlook is bullish, with 2027 avg $36.31 (ROI 24.1), 2028 avg $43.15 (ROI 47.4), 2029 avg $54.48 (ROI 86.1), 2030 avg $57.34 (ROI 95.9), 2031 avg $57.51 (ROI 96.5), 2032 avg $60.27 (ROI 105.9), 2033 avg $63.70 (ROI 117.6), 2034 avg $80.74 (ROI 175.8), 2035 avg $94.86 (ROI 224.1). The forecast extends to 2040 with avg $116.60 (ROI 298.4) and to 2050 with avg $267.96 (ROI 815.5).
The implied bullish trajectory comes with inherent uncertainty and is not a guarantee.
Tap a question to reveal the answer.
2030 min $39.98, avg $57.34, max $89.15; ROI 95.9%; sentiment BULLISH.
The forecast shows NEUTRAL in 2026, then BULLISH from 2027 onward, with positive ROI rising from 24.1% in 2027 to 815.5% by 2050.
Yes. The max forecast in 2033 is $106.39, indicating a potential surpassing of $100 by 2033; higher maxima are shown in later years (e.g., 2034 max $137.51, 2035 max $164.50, 2040 max $217.99, 2050 max $558.05).
Current price $29.27; Market cap $3.73B.
2040 min $65.24, avg $116.60, max $217.99; ROI 298.4; sentiment BULLISH.
Alumis Inc. Community Discussion
0Share your Alumis Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.